The Drug, Chemical & Associated Technologies Association (DCAT) has announced its news Board of Directors for year beginning 1st November 2017.
Joe Sutton, Global Director, Sourcing at Eli Lilly and Company, has been elected President of DCAT.
Also elected to serve as officers of DCAT are: Paolo Magri, Senior Vice President, Business Development at Advitech SA as First Vice President; Stephan Kutzer, CEO of Alcami Corporation, as Second Vice President; and Sean Diver, Director, Business Development, Early Intermediates at Lonza, Inc. as Third Vice President. All will serve one-year terms, beginning 1st November 2017.
In addition, the following individuals have been elected to serve one-year terms as Directors.
Anita Anderson, Senior Director, Business Development, Gyma Laboratories of America, Inc.
Elizabeth Iorns,CEO, Science Exchange.
Sally Macaluso, Vice President, J&J Business Services Procurement, Johnson & Johnson.
Kerri McCullough Wood, Senior Vice President, Head of Commercial, Teva API.
Oliver Technow, President, BioVectra, Inc.
Founded in 1890, DCAT is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.